Our Latest News

Stay tuned with Golden Helix Foundation

The Golden Helix Foundation, recognizing the fact that the most important prerequisites of the successful implementation of pharmacogenomics into the clinic is the increase of the general public’s awareness over the benefits of pharmacogenomics in rationalizing drug use, organized the 1st UPGx Personalized Medicine Public Day in London.

Read more ...

The 1st UPGx Personalized Medicine Public Day will be organised in London, UK on Wednesday December 6th, 2017 (18:30-21:00 pm) at the Royal Society.

One of the most important prerequisites of the successful implementation of pharmacogenomics into the clinic is the increase of the general public’s awareness over the benefits of pharmacogenomics in rationalising drug use.

Recognising this fact, the Golden Helix Foundation organizes in London the 1st UPGx Personalized Medicine Public Day. The theme of the meeting will be "Is Personalised Medicine available for all citizens?" and will be organized in the Royal Society in the afternoon of December 6th, 2017 (18:30 - 21:00 p.m.) and is part of the dissemination and outreaching activities of the Ubiquitous Pharmacogenomics (UPGx) project, funded by the European Commission (H2020-668353).

This event is meant for the general public, patient organisations, regulators, insurers and policy makers. Registration is FREE-OF-CHARGE. During the event, drinks and food will be served for free.

To register for this meeting, please click here.

We look forward to welcoming you to London in December.

The 1st UPGx Personalized Medicine Day, the first of a series of dissemination events for healthcare professionals and biomedical scientists that will be organized by the Golden Helix Foundation, in its function as the lead dissemination partner of the UPGx project, has been successfully held on Thursday December 1st, 2016 in Granada, Spain. The theme of the event, that was hosted at the newly built Salón de actos of the Hospital Campus de la Salud, was “Pharmacogenomics for the treatment of cardiovascular diseases”.

Read more ...
Page 1 of 4